2024-03-29
IL-41 in resistance to Kawasaki disease treatments
Hematology
In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41 levels were significantly increased in children resistant to Kawasaki disease treatments. Serum IL-41 levels were positively correlated with erythrocyte sedimentation rate, C-reactive protein and C-reactive protein/albumin ratio, but negatively correlated with albumin. Total number of fever days and neutrophil/lymphocyte ratio were independent predictors of resistance to intravenous immunoglobulin.
Last press reviews
PSMA, a revolution against prostate cancer
#ProstateCancer #Cancer #Prostate #Therapy #Inno...
HER2, the key to revolutionizing cancer treatment
#Oncology #Cancer #HER2 #TargetedTherapy #Therap...
CD47: The Tumor Shield Finally Broken?
#cancer #immunotherapy #CD47 #innovation ...